Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Paragon 28, Inc. (FNA : NYSE)
 
 • Company Description   
Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo.

Number of Employees: 343

 
 • Price / Volume Information   
Yesterday's Closing Price: $14.22 Daily Weekly Monthly
20 Day Moving Average: 239,368 shares
Shares Outstanding: 76.45 (millions)
Market Capitalization: $1,087.11 (millions)
Beta:
52 Week High: $25.41
52 Week Low: $12.35
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -18.32% -10.84%
12 Week -2.80% 5.05%
Year To Date -19.62% -4.79%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
14445 GRASSLANDS DRIVE
-
ENGLEWOOD,CO 80112
USA
ph: 730-399-3400
fax: -
ir@paragon28.com http://www.paragon28.com
 
 • General Corporate Information   
Officers
Albert DaCosta - Chief Executive Officer
Stephen M. Deitsch - Chief Financial Officer
Thomas Schnettler - Director
Alfred Grunwald - Director
Kristina Wright - Director

Peer Information
Paragon 28, Inc. (ABMD)
Paragon 28, Inc. (DMDS)
Paragon 28, Inc. (CPWY.)
Paragon 28, Inc. (EQUR)
Paragon 28, Inc. (ECIA)
Paragon 28, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 69913P105
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/08/22
Share - Related Items
Shares Outstanding: 76.45
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $1,087.11 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.03 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.23 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/08/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 5.89
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -71.43%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -3.28%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - 4.39
12/31/21 - 5.29
09/30/21 - 2.48
Quick Ratio
03/31/22 - 3.26
12/31/21 - 4.10
09/30/21 - 1.19
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -8.80
09/30/21 - -
Book Value
03/31/22 - 2.41
12/31/21 - 2.52
09/30/21 - 0.32
Inventory Turnover
03/31/22 - -
12/31/21 - 0.72
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.23
12/31/21 - 0.04
09/30/21 - 0.96
Debt-to-Capital
03/31/22 - 18.71
12/31/21 - 3.74
09/30/21 - 48.89
 

Powered by Zacks Investment Research ©